Morgan Lewis advised Replimune Group on the deal. Replimune Group Inc. announced its approximately $260 million public offering of 6,810,658 shares of common stock, inclusive of...
Replimune Group’s $260 Million Common Stock Offering
Strand Therapeutics’ $97 Million Series A Financing Round
Morgan Lewis & Bockius advised Strand Therapeutics in the transaction. Strand Therapeutics secured additional capital for its Series A financing round, which now totals $97 million. FPV...
Advent International’s Acquisition of Shiseido’s Cosmetic Brands
Morgan Lewis represented Shiseido Americas Corp on the deal. Weil advised Advent International. Shiseido Americas Corp, the regional US headquarters for Shiseido Company Limited, completed the...